Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention
Creators
- 1. University of Luebeck, Department of Radiation Oncology, Luebeck (Germany)
- 2. Medical Practice for Radiotherapy and Radiation Oncology, Hildesheim (Germany)
- 3. Friedrich-Alexander-University of Erlangen-Nuernberg, Department of Pediatrics and Adolescent Medicine, Nuremberg (Germany)
- 4. Medical Practice for Radiotherapy and Radiation Oncology, Hannover (Germany)
- 5. Hannover Medical School, Department of Radiotherapy and Special Oncology, Hannover (Germany)
- 6. Mayo Clinic, Department of Radiation Oncology, Scottsdale, AZ (United States)
Description
To assess the outcome of breast cancer patients with local recurrence who underwent partial external beam re-irradiation (re-RT) either as part of a second breast-conserving therapy or following mastectomy. Between 03/2004 and 10/2016, 83 breast cancer patients with local recurrence were treated with surgery followed by re-RT. The re-RT schedules were 45 Gy (1.8 Gy per fraction) administered either to the partial breast (n = 42) or mastectomy scar (n = 41). The patients and tumor characteristics predictive of local control, distant control, and survival (overall and breast-cancer specific) were evaluated by univariate and multivariate analyses. The median follow-up was 35 months (range 3-143 months). The median time interval between the first irradiation and re-RT was 117 months (range 16-357 months). The prognostic factors for favorable overall survival rates were younger age (p = 0.045), lower T-category (p = 0.019), and N0 category (p = 0.005). N0 was also superior to N+ with respect to outfield recurrences (p = <0.001) and breast cancer-specific survival (p = 0.025). Acute and late skin toxicity was generally low (<grade 3). Re-RT with 45 Gy (1.8 Gy per fraction) for partial breast or mastectomy scar after the second surgery resulted in high local control rates and tolerable skin toxicity. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00066-018-1315-1Abstract (German)
Das onkologische Ergebnis nach partieller perkutaner Rebestrahlung (Re-RT) bei Brustkrebspatientinnen mit einem Lokalrezidiv nach Mastektomie und/oder nach brusterhaltender Operation zu untersuchen. Zwischen 03/2004 und 10/2016 erhielten 83 Patienten postoperativ nach einem Lokalrezidiv des Mammakarzinoms eine perkutane Re-RT. Die Dosierung war 45 Gy (1,8-Gy-Einzeldosis) partiell auf die Brust (n = 42) oder auf die Mastektomienarbe (n = 41). Die Patienten- und Tumorcharakteristika wurden univariat und multivariat hinsichtlich lokaler und distanter Kontrolle, als auch auf das Ueberleben (gesamt- und karzinomspezifisch) untersucht. Die mediane Nachbeobachtungszeit betrug 35 Monate (Spanne 3-143 Monate). Das mediane Intervall zwischen erster Bestrahlung und Re-RT war 117 Monate (Spanne 16-357 Monate). Prognostisch guenstig fuer das Gesamtueberleben waren juengeres Alter (p = 0,045), kleiner Rezidivtumor (p = 0,019) und kein Lymphknotenbefall (p = 0,005). Patientinnen mit N0-Status hatten im Vergleich zu N+-Patientinnen weniger Rezidive ausserhalb des Bestrahlungsfelds (p = <0,001) und ein besseres brustkrebsspezifisches Ueberleben (p = 0,025). Grundsaetzlich traten ueberwiegend leichte und moderate (<Grad 3) akute und chronische Hautveraenderungen auf. Die Re-RT mit 45 Gy nach Mastektomie oder brusterhaltender Operation erzielte ein gutes onkologisches Outcome und war zudem gut vertraeglich. (orig.)Additional details
Identifiers
Publishing Information
- Journal Title
- Strahlentherapie und Onkologie
- Journal Volume
- 194
- Journal Issue
- 9
- Journal Page Range
- p. 806-814
- ISSN
- 0179-7158
- CODEN
- STONE4
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 49084692
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; COMPUTERIZED TOMOGRAPHY; DELAYED RADIATION EFFECTS; EXTERNAL BEAM RADIATION THERAPY; FRACTIONATED IRRADIATION; GY RANGE 01-10; GY RANGE 10-100; MAMMARY GLANDS; MULTIVARIATE ANALYSIS; PLANNING; SURGERY; SURVIVAL CURVES; SURVIVAL TIME; TOXICITY
- Descriptors DEC
- ABSORBED DOSE RANGE; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; BODY; DIAGNOSTIC TECHNIQUES; DISEASES; GLANDS; GY RANGE; IRRADIATION; MATHEMATICS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIATION DOSE RANGES; RADIATION EFFECTS; RADIOLOGY; RADIOTHERAPY; STATISTICS; THERAPY; TOMOGRAPHY